Amneal Pharmaceuticals, Inc. (AMRX) delivered a return of 104.16% over the past year. Since AMRX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Amneal Pharmaceuticals, Inc. one year ago would be worth $20,416 today, representing a gain of $10,416.

Amneal Pharmaceuticals, Inc. (AMRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AMRX, the total return equals the price-only return.

Yes, Amneal Pharmaceuticals, Inc. (AMRX) outperformed the S&P 500 by 79.17 percentage points over the past year. AMRX delivered a total return of 104.16%, compared to the S&P 500's 24.99%. This 79.17pp alpha means investors in AMRX earned more than a passive S&P 500 index fund.

Amneal Pharmaceuticals, Inc. (AMRX) experienced a maximum drawdown of -21.63% over the past year, declining from its peak on 2026-02-17 to its trough on 2026-05-19. The stock recovered to its prior peak by 2026-06-10. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Amneal Pharmaceuticals, Inc. (AMRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -49.3% (-6.6% CAGR) — $10,000 would have grown to $5,070. Over 20 years: 241.3% total return (6.3% CAGR) — $10,000 → $34,127. Over 30 years: 241.3% total return (4.2% CAGR) — $10,000 → $34,127. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Amneal Pharmaceuticals, Inc.'s best calendar year was 2023 with a total return of 187.7%. Its worst year was 2016 with a total return of -68.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 256.3 percentage points.